Literature DB >> 35876985

Establishment and characterization of IPS-OGC-C1: a novel induced pluripotent stem cell line from healthy human ovarian granulosa cells.

Zhiqiang Wang1,2, Xiaojia Hu1,2, Qiufen He2,3, Jingbo Lai1,2, Ruolang Pan4, Jing Zheng5,6, Ye Chen7,8.   

Abstract

Ovarian granulosa cell (OGC) is a critical somatic component of the ovary, which provides physical support and the microenvironment required for the developing oocyte. Human OGCs are easy to obtain and culture as a by-product of follicular aspiration performed during in vitro fertilization (IVF) procedures. Therefore, OGCs offer a potent cell source to generate induced pluripotent stem cells (iPSCs). This study established a novel OGCs-derived iPSC cell line from the follicular fluid of a healthy female donor with a Chinese Han genetic background and named it IPS-OGC-C1. IPS-OGC-C1 was verified for embryonic stem cell morphology, cell marker expression, alkaline phosphatase (AP) activity, transcriptomic profile, and pluripotency capability in developing all three embryonic germ layers in vivo and in vitro.
© 2022. The Author(s) under exclusive licence to Japan Human Cell Society.

Entities:  

Keywords:  Induced pluripotent stem cells; human ovarian granulosa cells; reprogramming

Mesh:

Year:  2022        PMID: 35876985     DOI: 10.1007/s13577-022-00757-7

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.374


  1 in total

1.  Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease.

Authors:  Yuan Tian; Grégory Seumois; Luzia M De-Oliveira-Pinto; Jose Mateus; Sara Herrera-de la Mata; Cheryl Kim; Denise Hinz; N D Suraj Goonawardhana; Aruna D de Silva; Sunil Premawansa; Gayani Premawansa; Ananda Wijewickrama; Angel Balmaseda; Alba Grifoni; Pandurangan Vijayanand; Eva Harris; Bjoern Peters; Alessandro Sette; Daniela Weiskopf
Journal:  Cell Rep       Date:  2019-12-24       Impact factor: 9.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.